FindTrial
Sign In

The influence of different doses of Lactose in cirrhotic patients after transjugular intrahepatic portosystemic shunt

The investigation of the high risk factors in the occurrence of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-14005663
Enrollment
Unknown
Registered
2014-12-11
Start date
2014-12-15
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cirrhosis

Interventions

Low-dose group:Low-dose of Lactose
High-dose group:High-dose of Lactose

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1) Diagnosis of cirrhosis; 2) Receiving successful TIPS creation.

Exclusion criteria

Exclusion criteria: 1) Severe organ failure or malignancy which may reduce the life expectancy; 2) Presence of HE (higher than West Heaven Criteria II); 3) Sever infection even sepsis; 4) Primary school education or below; 5) Color blindness and known photosensitive reflex epilepsy; 6) Alcohol abuse or history of psychiatric drugs; 7) refuse to participant.

Design outcomes

Primary

MeasureTime frame
Psychometric tests;Hepatic encephalopathy;Critical Flicker Frequency;—

Countries

China

Contacts

Public ContactLi Xiao
simonlixiao@gmail.com+86 18980601291

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026